Centene Corp (CNC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
47
About the Report
About the Report
Summary
Centene Corp (Centene) is a healthcare service provider that offers services to government sponsored healthcare programs with focus on under-insured and uninsured individuals. It provides health plans through Medicaid, Medicare and Health Insurance Marketplace contracts; and other health solutions through its specialty services companies. It provides a comprehensive range of managed healthcare products and services including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care (LTC), Foster Care, dual-eligible individuals (Duals), the Aged, blind or disabled program (ABD), Medicare and Health Insurance Marketplace. Centene through its specialty services companies offers life and health management, behavioral health and specialty rehabilitation therapies, managed vision, long-term care programs, telehealth services and pharmacy benefits management to healthcare organizations, employer groups, state programs and other commercial organizations. The company along with its subsidiaries operates across the US. Centene is headquartered in Saint Louis, Missouri, the US.
Centene Corp (CNC)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Centene Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Centene Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Centene Corp, Medical Devices Deals, 2012 to YTD 2018 9
Centene Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Centene Corp, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Centene Files Registration Statement For Public Offering Of Common Stock For USD 15.3 Million 11
Debt Offering 12
Centene Raises Additional USD200 Million in Public Offering 4.75% Senior Notes Due 2022 12
Centene Completes Public Offering Of Notes Due 2022 For USD 300 Million 13
Centene Completes Public Offering Of Notes Due 2017 For USD 175 Million 14
Asset Transactions 15
CVS Caremark Completes Acquisition Of Medicare PDP Business From Health Net For USD 160 Million 15
Acquisition 16
Centene Acquires Agate Resources For USD114 Million 16
Centene Completes Acquisition of Stake in Ribera Salud 17
Centene Completes Acquisition Of Majority Stake In U.S. Medical Management For USD213 Million 18
Centene Completes Acquisition Of AcariaHealth, Specialty Pharmacy Company, For USD 152 Million 19
Centene Corp-Key Competitors 20
Centene Corp-Key Employees 21
Centene Corp-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Joint Venture 24
Recent Developments 25
Strategy And Business Planning 25
Oct 10, 2018: Centene announces 2019 exchange participation 25
Financial Announcements 26
Oct 23, 2018: Centene reports 2018 third quarter results and increases 2018 guidance 26
Feb 06, 2018: Centene Reports 2017 Results And Increases 2018 Guidance 28
Dec 14, 2017: Centene Announces 2018 Guidance And Confirms 2017 Guidance 31
Oct 24, 2017: Centene Reports 2017 Third Quarter Results & Updates 2017 Guidance 32
Jul 25, 2017: Centene Reports 2017 Second Quarter Results & Raises 2017 Guidance 34
Apr 25, 2017: Centene Reports 2017 First Quarter Results & Updates 2017 Guidance 36
Feb 07, 2017: Centene Reports 2016 Fourth Quarter And Full Year Results 38
Corporate Communications 40
Jun 08, 2018: Centene Announces Leadership Rotation To Support Company's Growth And Development 40
Feb 05, 2018: Centene Appoints Jessica L. Blume As Board Director 41
Nov 16, 2017: Centene Announces Organizational Enhancements and Several Key Leadership Appointments 42
Legal and Regulatory 43
Jan 03, 2018: Nebraska Total Care earns NCQA Accreditation 43
Dec 06, 2017: Health Net Federal Services Earns URAC Health Utilization Management And Case Management Accreditations 44
Sep 19, 2017: Coordinated Care Awarded Commendable Accreditation Status From NCQA 45
Other Significant Developments 46
Jul 19, 2017: Centene Partners With Schnucks And People's Health Centers To Open Ferguson Clinic 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
List of Figure
List of Figures
Centene Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Centene Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Centene Corp, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Centene Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Centene Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Centene Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Centene Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Centene Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Centene Corp, Medical Devices Deals, 2012 to YTD 2018 9
Centene Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Centene Files Registration Statement For Public Offering Of Common Stock For USD 15.3 Million 11
Centene Raises Additional USD200 Million in Public Offering 4.75% Senior Notes Due 2022 12
Centene Completes Public Offering Of Notes Due 2022 For USD 300 Million 13
Centene Completes Public Offering Of Notes Due 2017 For USD 175 Million 14
CVS Caremark Completes Acquisition Of Medicare PDP Business From Health Net For USD 160 Million 15
Centene Acquires Agate Resources For USD114 Million 16
Centene Completes Acquisition of Stake in Ribera Salud 17
Centene Completes Acquisition Of Majority Stake In U.S. Medical Management For USD213 Million 18
Centene Completes Acquisition Of AcariaHealth, Specialty Pharmacy Company, For USD 152 Million 19
Centene Corp, Key Competitors 20
Centene Corp, Key Employees 21
Centene Corp, Subsidiaries 22
Centene Corp, Joint Venture 24
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.